INS and breast cancer: For example, Cao et al. provide insights into the role of breast cancer-derived EVPs and miR-122 in systemic glucose and insulin dysregulation, by demonstrating that breast cancer-derived EVPs impair insulin secretion and glucose homeostasis[111].